Wolters Kluwer Health - Lippincott Williams & Wilkins

Registered Users

User Name:
Password:
Register   Forgotten Password
Enter your email address:
  • Conferences
  • Free Content
  • Hot Topics
  • News
  • Archive
  • Contact Us
  • Home
  • Free Content
  • Hot Topics
  • News
  • Podcasts
  • About Us
  • Contact Us
  • Publish With Us
  • Conferences
  • Register

Banner image: Anaesthesiology Focus

You are here: Home » Oncology » XELOX as First-Line Chemotherapy With AGC

Triweekly Oxaliplatin Plus Oral Capecitabineas First-Line Chemotherapyin Elderly Patients With Advanced Gastric Cancer

Dong et al
American Journal of Clinical Oncology: 32(6) December 2009
ISSN: 0277-3732 • Frequency: 6/year • Impact Factor: 1.792 • Subscribe Now

The American Journal of Clinical Oncology is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists.

The emphasis of AJCO is on combined modality multidisciplinary loco-regional management of cancer. The journal also gives emphasis to translational research, outcome studies, and cost utility analyses, and includes opinion pieces and review articles.

The editorial board includes a large number of distinguished surgeons, radiation oncologists, medical oncologists, GYN oncologists, pediatric oncologists, and others who are internationally recognized for expertise in their fields.

Read this article

Bookmark and Share







Conferences


©2010 Lippincott Williams & Wilkins
Judd Associates: Sussex Web Design
  • Site Map
  • Accessibility
  • Privacy
Follow us on Facebook and Twitter